Brain Cancer Immunotherapy / Targeted Therapy
Learn More About Brain Cancer Immunotherapy: Chat with Us | Email Us
Immunotherapy / Targeted Therapy for Brain Cancer
The medical oncologists at Cancer Treatment Centers of America (CTCA) may use a variety of immunotherapies / targeted therapies to eliminate brain tumors.
Immunotherapies (also called biological therapies) and targeted therapies for brain cancer work to (1) stimulate the immune system to turn against a brain tumor, or (2) target specific pathways or abnormalities in brain tumor cells involved in tumor growth.
One targeted therapy used to treat brain tumors is AvastinTM (bevacizumab), which is given intravenously. A monoclonal antibody, this therapy works to stop the formation of new blood vessels that a brain tumor needs to grow (a process known as angiogenesis).
A common immunotherapy for brain cancer is a drug called Gleevac®. This drug works by helping the body produce larger amounts of substances called biological response modifiers, which help fight disease.
Another drug therapy, Everolimus (Afinitor®) is taken as a pill. It works to block a cell protein known as mTOR, which normally promotes cell growth and division.
Your CTCA care team will likely combine immunotherapy / targeted therapy with other brain cancer treatments, like chemotherapy. This treatment is often an option for brain cancer patients who have a tumor recurrence after previous brain cancer treatments.
Managing the Side Effects of Brain Cancer Immunotherapy
Immunotherapy / targeted drug therapy can cause side effects, such as low blood counts, tiredness, mouth sores, nausea, diarrhea, high blood pressure, and fluid buildup (usually in the legs).
Throughout your brain cancer treatment, your CTCA care team provides various supportive therapies, like nutrition therapy, naturopathic medicine, mind-body medicine, and oncology rehabilitation, to keep you strong, reduce side effects and improve your quality of your life.
Next Topic: Naturopathic Medicine for Brain Cancer
